Phase I/II/III Pharmacokinetic and Outcome Study of Insp

Project: Research project

Project Details

Description

Phase I/II/III Pharmacokinetic and Outcome Study of Inspiration's Recombinant Factor IX Product, IB1001, in Subjects with Hemophilia B
StatusActive
Effective start/end date5/14/1012/31/20

Funding

  • Inspiration Biopharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.